108 results on '"Perez, Edith A"'
Search Results
2. Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial
3. Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients
4. N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
5. Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer
6. Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers
7. Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
8. 5-Year Follow-Up of a Randomized Controlled Trial of Immediate Versus Delayed Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Breast Cancer Starting Letrozole After Tamoxifen: N03CC (Alliance) Trial
9. Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole
10. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
11. Acute stress impairs the retrieval of extinction memory in humans
12. Assessing the potential cost-effectiveness of retesting IHC0, IHC1+, or FISH-negative early stage breast cancer patients for HER2 status
13. Soluble Human Epidermal Growth Factor Receptor 2 (HER2) Levels in Patients With HER2-Positive Breast Cancer Receiving Chemotherapy With or Without Trastuzumab: Results From North Central Cancer Treatment Group Adjuvant Trial N9831
14. Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831
15. A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
16. TSPYL5 SNPs: Association with Plasma Estradiol Concentrations and Aromatase Expression
17. North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane
18. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer
19. A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast cancer: an Eastern Cooperative Oncology Group Study (E1103)
20. Response
21. Current and emerging targeted therapies for metastatic breast cancer
22. Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
23. Final 5-year results of Z-FAST trial: Adjuvant Zoledronic Acid Maintains Bone Mass in Postmenopausal Breast Cancer Patients Receiving Letrozole
24. Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria
25. Treatment of HER2-positive breast cancer: current status and future perspectives
26. A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines
27. Highlights from the 3rd Breast–Gynecological International Cancer Conference 2011
28. Ixabepilone plus capecitabine in metastatic breast cancer patients with reduced performance status previously treated with anthracyclines and taxanes: a pooled analysis by performance status of efficacy and safety data from 2 phase III studies
29. Challenges in Applying Recent Clinical Trial Data to the Care of Patients
30. Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer
31. Adjuvant Trastuzumab for HER2-Positive Early Breast Cancer:: A Review of Clinical Data With Nursing Implications
32. Changes to Adjuvant Systemic Therapy in Breast Cancer: A Decade in Review
33. Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer
34. Adjuvant therapy of triple negative breast cancer
35. Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy
36. In Newly Diagnosed Breast Cancer, Screening MRI of the Contralateral Breast Detects Mammographically Occult Cancer, Even in Elderly Women: The Mayo Clinic in Florida Experience
37. Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: A Southwest Oncology Group study (S0012)
38. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
39. Biologic therapy of breast cancer: Focus on co-inhibition of endocrine and angiogenesis pathways
40. Quality of Life After Breast Cancer Surgery: What Have We Learned and Where Should We Go Next?
41. Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
42. Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer
43. Zoledronic Acid Effectively Prevents Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
44. Evaluation of Glutathione Metabolic Genes on Outcomes in Advanced Non-small Cell Lung Cancer Patients after Initial Treatment with Platinum-Based Chemotherapy: An NCCTG-97-24-51 Based Study
45. Treatment of metastatic breast cancer: Looking towards the future
46. Comprehensive Diagnostic Program for Medically Underserved Women With Abnormal Breast Screening Evaluations in an Urban Population
47. Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer
48. Predictive Value of Contaminated Contact Lens Systems to Predictive Etiologic Agent in Contact Lens Associated Microbial Keratitis: Poster No.: CN-D3-100 Panel No.: 100
49. Detection of Reducted in vitro Vancomycin Susceptibility among Common Ocular Pathogens: Rm 311-312 14:00-15:30
50. Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.